MRA Implementation Goals Set By Industry Incongruent With FDA Timeframes
This article was originally published in The Gray Sheet
Executive Summary
FDA should commence in March observed audits and review of 510(k)s and EC type tests under the U.S./EU mutual recognition agreement, the Health Industry Manufacturers Association and the Trans Atlantic Business Dialogue suggest.